ProCE Banner Activity

PrEP Data From CROI 2023: Protecting Patients From HIV

Conference Coverage
Clinical Thought

Read my take on practice-changing studies evaluating long-acting injectable and oral options for HIV PrEP presented at CROI 2023.

Released: March 20, 2023

Expiration: March 18, 2024

Share

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Monica Gandhi, MD, MPH

Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
University of California, San Francisco (UCSF)
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.